Anna Bucsics
Anna Bucsics publishes mostly in Economics and Econometrics, Family Practice and Cardiology and Cardiovascular Medicine, on topics such as Pharmaceutical Economics and Policy, Health Systems, Economic Evaluations, Quality of Life and Medication Adherence and Compliance.
- World rank
- #333,475 of 7,710,434 ranked researchers
- Rank in Sweden
- #3,886 of 71,437
- Works
- 50
- Citations
- 1.8k
- Citations per work
- 35.6
What does Anna Bucsics research?
Anna Bucsics's work is mostly in Economics, Econometrics and Finance (55%), Medicine (20%), Pharmacology, Toxicology and Pharmaceutics (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Social Sciences2754.7%
- Everything else1121.6%
- Health Sciences1019.6%
- Medicine1019.6%
- Life Sciences24.1%
- 1Economics and Econometrics55% of their works
- 2Family Practice7% of their works
- 3Cardiology and Cardiovascular Medicine5% of their works
- 4Pharmacology4% of their works
- 5Geriatrics and Gerontology3% of their works
- 6Pediatrics, Perinatology and Child Health3% of their works
Research topics
- Pharmaceutical Economics and Policy
- Health Systems, Economic Evaluations, Quality of Life
- Medication Adherence and Compliance
- Pharmaceutical industry and healthcare
- Pharmaceutical Practices and Patient Outcomes
- Pharmaceutical studies and practices
- Economic and Financial Impacts of Cancer
- Biosimilars and Bioanalytical Methods
Which keywords describe Anna Bucsics's research?
The keywords of their largest research topics: Pharmaceutical Industry, Drug Development Costs, Generic Drugs, Cost-effectiveness Analysis, Quality of Life, Medication Adherence, Patient Compliance and Treatment Adherence.
- Biosimilars
- Polypharmacy
- Off-Label Drug Use
- Financial Toxicity
- Conflict of Interest
- Treatment Adherence
- Medication Adherence
- Cost-effectiveness Analysis
- Drug Development Costs
- Pharmaceutical Industry
- Generic Drugs
- Quality of Life
- Patient Compliance
- Clinical Trials
- Cost of Care
- Inappropriate Medication Use
- Pediatric Pharmacokinetics
- Research Outcome
- Immunogenicity
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Pharmaceutical Industry452 topics
- Drug Development Costs401 topic
- Generic Drugs401 topic
- Cost-effectiveness Analysis351 topic
- Quality of Life351 topic
- Medication Adherence162 topics
- Patient Compliance111 topic
- Treatment Adherence111 topic
- Clinical Trials102 topics
- Conflict of Interest51 topic
- Cost of Care51 topic
- Financial Toxicity51 topic
- Inappropriate Medication Use51 topic
- Off-Label Drug Use51 topic
- Pediatric Pharmacokinetics51 topic
- Polypharmacy51 topic
- Research Outcome51 topic
- Biosimilars41 topic
- Immunogenicity41 topic
Where does Anna Bucsics work?
Anna Bucsics's main affiliation in the publication record is Karolinska Institutet, Sweden.
How many publications and citations does Anna Bucsics have?
OpenAlex counts 50 works and 1,781 citations for Anna Bucsics, an h-index of 23, ranking #333,475 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Anna Bucsics. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.